Thane Wettig
Known title: CEOCIK: 0001815638
Thane Wettig's purchase track record
How the stock did after each of Thane Wettig's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 5 since August 26, 2021
Stock higher 6 months later
50%
3 months: 40%
Median 6-month return
+3.1%
3 months: -17.5%
Beat the S&P 500
50%
median -8.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/14/2026 | KYNB | $20K | +0.4% | pending | — |
| 11/13/2025 | KYNB | $34K | -17.5% | -22.7% | +11.3% |
| 3/24/2025 | KYNB | $51K | -41.5% | +32.6% | +16.1% |
| 3/7/2024 | KYNB | $95K | -33.5% | -76.3% | +6.7% |
| 8/26/2021 | KYNB | $36K | +6.3% | +28.9% | -4.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| KYNB | ▼ Sell | Tax Withholding | 209 | $2K | 9/6/2026 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 198 | $1K | 6/6/2026 | View on chart |
| KYNB | ▲ Buy | Open Market | 2,800 | $20K | 5/14/2026 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 277 | $2K | 3/6/2026 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 259 | $2K | 12/6/2025 | View on chart |
| KYNB | ▲ Buy | Open Market | 2,700 | $25K | 11/17/2025 | View on chart |
| KYNB | ▲ Buy | Open Market | 1,000 | $9K | 11/13/2025 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 248 | $3K | 9/6/2025 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 246 | $2K | 6/6/2025 | View on chart |
| KYNB | ▲ Buy | Open Market | 145,000 | $51K | 3/24/2025 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 22,038 | $9K | 3/6/2025 | View on chart |
| KYNB | ▲ Buy | Grant | 781 | $0 | 3/6/2025 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 367 | $143 | 3/6/2025 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 2,363 | $808 | 12/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 2,363 | $922 | 9/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 20,840 | $10K | 8/1/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 782 | $884 | 6/22/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 2,255 | $3K | 6/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 20,840 | $24K | 5/1/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 782 | $2K | 3/22/2024 | View on chart |
| KYNB | ▲ Buy | Open Market | 50,000 | $95K | 3/7/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 4,209 | $8K | 3/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 326 | $610 | 3/6/2024 | View on chart |
| KYNB | ▲ Buy | Grant | 781 | $0 | 3/6/2024 | View on chart |
| KYNB | ▲ Buy | Grant | 166,000 | $0 | 2/21/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 23,490 | $56K | 2/1/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 819 | $622 | 12/22/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,680 | $974 | 12/6/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 21,841 | $12K | 11/1/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 819 | $644 | 9/22/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,680 | $2K | 9/6/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 200,000 | $0 | 8/7/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 791 | $13K | 6/23/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 472 | $8K | 6/7/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 1,286 | $22K | 6/7/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 905 | $17K | 3/23/2023 | View on chart |
| KYNB | ▼ Sell | Gift | 1,000 | $0 | 3/20/2023 | View on chart |
| KYNB | ▼ Sell | Gift | 2,343 | $0 | 3/20/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 2,938 | $59K | 3/10/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 4,731 | $96K | 3/10/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 6,265 | $133K | 3/8/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 9,338 | $0 | 3/8/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 5,799 | $0 | 3/8/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 25,000 | $0 | 2/21/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 734 | $12K | 12/23/2022 | View on chart |
| KYNB | ▼ Sell | Open Market | 382 | $6K | 12/8/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 655 | $8K | 9/22/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 360 | $4K | 9/6/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 655 | $7K | 6/22/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 360 | $3K | 6/6/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 655 | $9K | 3/22/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,706 | $22K | 3/7/2022 | View on chart |
| KYNB | ▲ Buy | Grant | 45,000 | $0 | 2/14/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 517 | $8K | 12/22/2021 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 620 | $6K | 9/22/2021 | View on chart |
| KYNB | ▲ Buy | Open Market | 3,100 | $36K | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Kyntra Bio Names Andrew Singer to Board
Kyntra Bio has added Andrew E. Singer, MBA, to its board of directors. The move expands the company’s leadership team and could bring new expertise to its strategic planning. The appointment follows the company’s ongoing efforts to strengthen governance and support its growth initiatives. Investors may view the change as a sign of continued focus on development and operational improvement.
Kyntra Bio Names Andrew Singer to Board. Kyntra Bio has added Andrew E. Singer, MBA, to its board of directors. The move expands the company’s leadership team and could bring new expertise to its strategic planning. The appointment follows the company’s ongoing efforts to strengthen governance and support its growth initiatives. Investors may view the change as a sign of continued focus on development and operational improvement.